Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster immune response to IXIARO in travellers previously vaccinated with mouse-brain-derived Japanese encephalitis vaccine
2010-023300-27Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Dec 2010
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of Japanese encephalitis inactivated vaccine and Japanese encephalitis vaccine in Japanese encephalitis (JE) (4 arms), sponsored by Helsinki University Hospital. Primary endpoints: Seroconversion rates and Levels of neutralizing antibodies. Started Dec 2010; status: completed.
02
Drugs
Japanese encephalitis inactivated vaccineJapanese encephalitis vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on 2010-023300-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023300-27.